JBT Marel (JBTM) is an interesting investment opportunity, given its unique combination of secular growth, high margin recurring revenue, and robust free cash flow generation, Oppenheimer said in a Thursday report.
The company's protein segment is a leader in protein processing equipment, while its prepared foods business holds top market positions in downstream value-added preparation, preservation, and packaging of ready-to-eat foods, the Oppenheimer analysts said.
JBT Marel appears positioned to outgrow the market by 200 to 300 basis points and deliver an organic revenue compound annual growth rate of 5% to 7% from fiscal 2025 through 2028, driven by revenue synergies and growth initiatives, according to the report.
Oppenheimer initiated coverage of JBT Marel with an outperform rating and a $175 price target.
Price: $128.78, Change: $+0.07, Percent Change: +0.05%